Creo Cash And Short Term Investments vs Total Current Liabilities Analysis

CREO Stock   16.00  0.13  0.81%   
Creo Medical financial indicator trend analysis is way more than just evaluating Creo Medical Group prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Creo Medical Group is a good investment. Please check the relationship between Creo Medical Cash And Short Term Investments and its Total Current Liabilities accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creo Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Cash And Short Term Investments vs Total Current Liabilities

Cash And Short Term Investments vs Total Current Liabilities Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Creo Medical Group Cash And Short Term Investments account and Total Current Liabilities. At this time, the significance of the direction appears to have weak relationship.
The correlation between Creo Medical's Cash And Short Term Investments and Total Current Liabilities is 0.39. Overlapping area represents the amount of variation of Cash And Short Term Investments that can explain the historical movement of Total Current Liabilities in the same time period over historical financial statements of Creo Medical Group, assuming nothing else is changed. The correlation between historical values of Creo Medical's Cash And Short Term Investments and Total Current Liabilities is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash And Short Term Investments of Creo Medical Group are associated (or correlated) with its Total Current Liabilities. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Current Liabilities has no effect on the direction of Cash And Short Term Investments i.e., Creo Medical's Cash And Short Term Investments and Total Current Liabilities go up and down completely randomly.

Correlation Coefficient

0.39
Relationship DirectionPositive 
Relationship StrengthVery Weak

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Creo Medical Group balance sheet. This account contains Creo Medical investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Creo Medical Group fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Total Current Liabilities

Total Current Liabilities is an item on Creo Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Creo Medical Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.
Most indicators from Creo Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Creo Medical Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Creo Medical Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Selling General Administrative is likely to gain to about 42.5 M in 2024, whereas Tax Provision is likely to drop (2.9 M) in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense237K248K400K420K
Depreciation And Amortization2.6M3.1M3.4M3.6M

Creo Medical fundamental ratios Correlations

0.850.830.80.380.860.770.950.660.880.95-0.770.840.77-0.410.81-0.640.690.870.70.780.860.910.710.910.76
0.850.990.850.060.950.670.710.50.620.78-0.610.830.7-0.260.82-0.930.460.650.470.920.740.680.610.70.47
0.830.990.890.110.970.720.720.420.660.76-0.670.870.76-0.180.86-0.920.390.660.520.950.780.720.670.650.51
0.80.850.890.340.910.870.750.230.810.67-0.840.940.91-0.090.92-0.770.370.810.690.850.890.830.860.540.69
0.380.060.110.340.30.710.52-0.240.690.21-0.780.550.630.360.570.230.00.490.890.270.30.680.710.130.88
0.860.950.970.910.30.810.780.330.760.73-0.780.940.84-0.070.94-0.850.360.720.680.970.760.810.770.620.65
0.770.670.720.870.710.810.80.060.880.6-0.970.960.990.170.96-0.470.20.740.920.740.760.930.990.460.89
0.950.710.720.750.520.780.80.560.930.89-0.820.830.79-0.30.8-0.50.610.880.790.710.840.950.760.840.84
0.660.50.420.23-0.240.330.060.560.360.81-0.080.180.07-0.890.12-0.40.890.510.010.270.510.34-0.020.910.15
0.880.620.660.810.690.760.880.930.360.78-0.940.870.86-0.180.84-0.390.540.930.890.690.850.970.850.70.95
0.950.780.760.670.210.730.60.890.810.78-0.620.680.6-0.580.64-0.590.790.810.530.670.840.790.540.970.62
-0.77-0.61-0.67-0.84-0.78-0.78-0.97-0.82-0.08-0.94-0.62-0.93-0.96-0.12-0.920.39-0.26-0.8-0.96-0.72-0.78-0.95-0.97-0.48-0.95
0.840.830.870.940.550.940.960.830.180.870.68-0.930.960.081.0-0.680.270.770.850.890.790.920.930.550.82
0.770.70.760.910.630.840.990.790.070.860.6-0.960.960.160.96-0.550.190.730.880.760.790.920.990.450.85
-0.41-0.26-0.18-0.090.36-0.070.17-0.3-0.89-0.18-0.58-0.120.080.160.140.2-0.92-0.430.21-0.01-0.41-0.090.23-0.710.03
0.810.820.860.920.570.940.960.80.120.840.64-0.921.00.960.14-0.660.210.730.860.90.750.90.930.50.81
-0.64-0.93-0.92-0.770.23-0.85-0.47-0.5-0.4-0.39-0.590.39-0.68-0.550.2-0.66-0.3-0.45-0.21-0.83-0.62-0.46-0.44-0.51-0.18
0.690.460.390.370.00.360.20.610.890.540.79-0.260.270.19-0.920.21-0.30.730.190.270.640.450.130.880.36
0.870.650.660.810.490.720.740.880.510.930.81-0.80.770.73-0.430.73-0.450.730.710.640.910.860.70.770.82
0.70.470.520.690.890.680.920.790.010.890.53-0.960.850.880.210.86-0.210.190.710.630.610.910.910.420.97
0.780.920.950.850.270.970.740.710.270.690.67-0.720.890.76-0.010.9-0.830.270.640.630.680.730.690.550.58
0.860.740.780.890.30.760.760.840.510.850.84-0.780.790.79-0.410.75-0.620.640.910.610.680.840.750.750.7
0.910.680.720.830.680.810.930.950.340.970.79-0.950.920.92-0.090.9-0.460.450.860.910.730.840.910.70.94
0.710.610.670.860.710.770.990.76-0.020.850.54-0.970.930.990.230.93-0.440.130.70.910.690.750.910.390.87
0.910.70.650.540.130.620.460.840.910.70.97-0.480.550.45-0.710.5-0.510.880.770.420.550.750.70.390.53
0.760.470.510.690.880.650.890.840.150.950.62-0.950.820.850.030.81-0.180.360.820.970.580.70.940.870.53
Click cells to compare fundamentals

Creo Medical Account Relationship Matchups

Creo Medical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets88.3M92.5M100.6M75.3M76.6M80.4M
Other Current Liab3.2M9.4M10.3M7.5M3.8M2.7M
Total Current Liabilities5.1M18.0M19.7M17.5M9.9M5.3M
Accounts Payable923.3K2.5M3.5M4.3M2.5M2.6M
Total Liab5.6M29.7M27.3M25.9M16.8M17.6M
Property Plant Equipment906.3K1.3M3.4M8.6M9.9M10.4M
Cash81.0M45.1M43.5M13.1M3M2.9M
Net Receivables4.1M4.2M3.9M5M6.4M6.7M
Total Stockholder Equity82.7M62.8M73.3M49.4M59.8M31.8M
Retained Earnings(37.2M)(57.6M)(82.2M)(109.1M)(144.4M)(137.2M)
Inventory727.2K6.8M8.5M9.3M8.1M8.5M
Property Plant And Equipment Net1.3M3.4M8.6M10.2M9.1M9.6M
Net Debt(80.3M)(32.7M)(33.0M)(3.0M)5.3M5.6M
Non Current Assets Total2.2M33.0M39.4M41.7M38.7M40.6M
Non Currrent Assets Other(2.0M)(18.3M)(18.6M)(19.6M)200K210K
Cash And Short Term Investments81.0M45.1M43.5M13.1M18.5M26.4M
Common Stock Shares Outstanding125.8M161.6M170.4M187.9M313.0M328.7M
Liabilities And Stockholders Equity88.3M92.5M100.6M75.3M76.6M55.6M
Non Current Liabilities Total543.9K11.6M7.6M8.5M6.9M3.9M
Other Current Assets4.3M3.3M5.3M6.3M4.9M3.5M
Other Stockholder Equity101.5M101.7M135.8M149.5M180.9M189.9M
Total Current Assets86.1M59.5M61.2M33.7M37.9M32.9M
Accumulated Other Comprehensive Income4.6M4.9M5.8M8.8M22.9M24.0M
Common Stock150.4K158K181K182K400K420K
Net Tangible Assets47.4M81.9M34.8M46.4M53.4M29.1M
Other Assets19.3K128.4K1.1M1.01.151.09
Short Long Term Debt Total717.1K12.4M10.6M10.1M8.3M5.2M
Long Term Debt357.3K5.2M3.8M4.9M4.4M2.4M
Short Long Term Debt173.2K5.2M4.7M1.6M2.5M1.6M
Short Term Debt173.2K5.8M5.4M4.6M3.1M2.2M
Intangible Assets865.2K28.5M27.3M27.6M7.1M10.1M
Current Deferred Revenue(4.0M)161K214K(200K)(230K)(241.5K)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creo Stock Analysis

When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.